NCT05520567 2026-03-04A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaAstellas Pharma IncPhase 1/2 Active not recruiting70 enrolled
NCT03625505 2021-09-14A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid LeukemiaAbbViePhase 1 Completed61 enrolled